Status:
UNKNOWN
The Study of Metabolic Syndrome in Hemodialysis Patients
Lead Sponsor:
Far Eastern Memorial Hospital
Collaborating Sponsors:
National Taiwan University Hospital
Conditions:
Hemodialysis
Metabolic Syndrome X
Eligibility:
All Genders
18+ years
Brief Summary
Metabolic syndrome (MS), comprised of central obesity, glucose intolerance, hyperinsulinemia, low HDL-cholesterol (HDL-C), high triglyceride (TG) and hypertension, results in markedly increased risk f...
Eligibility Criteria
Inclusion
- We will enroll all the patients who receive maintenance HD more than three months in our HD center.
Exclusion
- The patients who are hospitalizing, suffered from active malignancy, active infections, recent cardiovascular events and surgery will be excluded in the beginning of study.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2008
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00632879
Start Date
March 1 2007
End Date
March 1 2008
Last Update
July 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
PanChiao, Taipei, Taiwan, 220